Dominik Paul Modest

First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAFV600E-mutated metastatic colorectal can...

European journal of cancer (Oxford, England : 1990) · 2026-01

Individual Patient Data Meta-analyse of Consensus Molecular Subtypes as Biomarkers of Eerstelijns Behandeling in RAS ...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026-01

Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wil...

European journal of cancer (Oxford, England : 1990) · 2026-01

Health-related quality of life in patiënten met KRASG12C-mutated chemorefractory metastatic colorectal cancer treated...

The Lancet. Oncology · 2025-09

Totale overleving Analysis of the Fase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Ch...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025-07

Molecular hyperselection for optimal choice of eerstelijns targeted therapy independent of primary tumor sidedness: A...

European journal of cancer (Oxford, England : 1990) · 15 mei 2025

FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining eerstelijns treatment s...

European journal of cancer (Oxford, England : 1990) · 2 mei 2025

Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Geran...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 april 2025

FOLFOXIRI plus cetuximab of bevacizumab bij BRAF V600E CRC: FIRE-4.5 fase II

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 september 2023

QoL bij RAS-wildtype CRC onder panitumumab versus bevacizumab: PARADIGM analyse

European journal of cancer (Oxford, England : 1990) · 2023-09

CMS als biomarker voor 5-FU/LV-onderhoud bij gemetastaseerd CRC

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 juni 2023

FOLFOX plus panitumumab of FOLFOX alleen na R0/1 resectie bij RAS-wildtype CRC-levermetastasen: PANTER fase II

European journal of cancer (Oxford, England : 1990) · 2022-09

Panitumumab plus 5FU/LV versus 5FU/LV als onderhoud na eerstelijns bij CRC: SAPPHIRE-like analyse

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 januari 2022

Sequentiële versus combinatietherapie bij gemetastaseerd CRC: CAIRO3-gerelateerde analyse

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 januari 2019

Relevantie van primaire tumorlocatie bij gemetastaseerd colorectaal carcinoom: meta-analyse

European journal of cancer (Oxford, England : 1990) · 2017-01